Showing results (801-810 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|July 31, 2014
Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanibSantiago Cabezas-Camarero, Javier Puente, Aránzazu Manzano, et al.
Anti-Cancer Drugs|August 5, 2014
BI 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatmentsRodrigo F E Bogado, Julia A Pezuk, Harley F de Oliveira, et al.
Anti-Cancer Drugs|September 3, 2013
Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemiaMayrim L Pérez, Sarah Culver, Jennifer L Owen, et al.
Anti-Cancer Drugs|May 23, 2013
Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cellsRuifang Liu, Zhifei Cao, Yanyan Pan, et al.
Anti-Cancer Drugs|May 15, 2013
Antiproliferative activity of the dimeric phloroglucinol and benzophenone derivatives of Hypericum spp. native to southern BrazilAmanda V Pinhatti, Francisco M C de Barros, Caroline B de Farias, et al.
Anti-Cancer Drugs|April 5, 2013
Phase I and pharmacokinetic study of bexarotene in combination with gefitinib in the third-line treatment of non-small-cell lung cancer: brief reportSukhmani K Padda, Laveena Chhatwani, Lisa Zhou, et al.
Anti-Cancer Drugs|April 5, 2013
Fengycin inhibits the growth of the human lung cancer cell line 95D through reactive oxygen species production and mitochondria-dependent apoptosisHongping Yin, Chuanlong Guo, Ying Wang, et al.
Anti-Cancer Drugs|March 8, 2013
Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cellsZiyan Lu, Yufeng Tian, Helen R Salwen, et al.
Anti-Cancer Drugs|February 5, 2013
Cytotoxicity of chemotherapeutic agents in glyceraldehyde-3-phosphate dehydrogenase-depleted human lung carcinoma A549 cells with the accelerated senescence phenotypeManali Phadke, Natalia Krynetskaia, Evgeny Krynetskiy
Anti-Cancer Drugs|January 30, 2013
Sensitivity of gastric adenocarcinoma and normal cell lines against combined or conjugated antimetabolitesJürgen Weinreich, Florian Struller, Markus Küper, et al.
Pageof 464